Fig. 2From: Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy a Schematic view of DOT1L principal domains. b Structures of the methyl donor SAM, its enzymatic product SAH and of two DOT1L inhibitors. The SAM-like shared moiety is highlighted in bold Back to article page